Accelerating clinical development of idasanutlin through a physiologically-based pharmacokinetic modeling risk assessment for CYP450 isoenzyme related drug-drug interactions
2019 ◽
Vol 59
(6)
◽
pp. 880-889
◽
2015 ◽
Vol 36
(8)
◽
pp. 507-519
◽
2020 ◽
Vol 9
(2)
◽
pp. 106-114
◽
2015 ◽
Vol 4
(5)
◽
pp. 286-294
◽
2015 ◽
Vol 77
◽
pp. 216-229
◽
2014 ◽
Vol 43
(3)
◽
pp. 325-334
◽